|
 |
|
|||||||
|
|||||||||
© 2001 by the American Diabetes Association, Inc.
Epidemiology/Health Services/Psychosocial Research |
Postchallenge Hyperglycemia and Mortality in a National Sample of U.S. Adults
1 Johns Hopkins Medical Institutions, Baltimore, Maryland
2 Global Epidemiology, CS&-E, Novartis Farmacéutica, Barcelona, Spain
3 Health Care Management, Novartis Pharmaceuticals, East Hanover, New Jersey
OBJECTIVE—Although postchallenge hyperglycemia is a well-established feature of type 2 diabetes, its association with risk of mortality is uncertain. Therefore, the aim of this study was to assess the independent association of fasting and 2-h glucose levels with all-cause and cardiovascular disease (CVD) mortality.
RESEARCH DESIGN AND METHODS—We analyzed data from the Second National Health and Nutrition Examination Survey (NHANES II) Mortality Study, a prospective cohort study of U.S. adults examined in the NHANES II, and focused on the 3,092 adults aged 30–74 years who underwent an oral glucose tolerance test at baseline (1976–1980). Deaths were identified from U.S. national mortality files from 1976 to 1992. To account for the complex survey design, we used SUDAAN statistical software for weighted analysis.
RESULTS—Compared with their normoglycemic counterparts (fasting glucose [FG] <7.0 and 2-h glucose <7.8 mmol/l), adults with fasting and postchallenge hyperglycemia (FG 
7.0 and 2-h glucose 11.1 mmol/l) had a twofold higher risk of death after 16 years of follow-up (age- and sex-adjusted relative hazard [RH] 2.1, 95% CI 1.4–3.2). However, adults with isolated postchallenge hyperglycemia (FG <7.0 and 2-h glucose 11.1 mmol/l) were also at higher risk of death (1.6, 1.0–2.6). In proportional hazards analysis, FG (fully adjusted RH 1.10 per 1 SD; 95% CI 1.01, 1.22) and 2-h glucose (1.14, 1.00–1.29) showed nearly identical predictive value for mortality. Similar trends were observed for CVD mortality.
CONCLUSIONS—These results suggest that postchallenge hyperglycemia is associated with increased risk of all-cause and CVD mortality independently of other CVD risk factors.
Abbreviations: ADA, American Diabetes Association • CVD, cardiovascular disease • FG, fasting glucose • IGT, impaired glucose tolerance • NHANES II, Second National Health and Nutrition Examination Survey • OGTT, oral glucose tolerance test • PCH, postchallenge hyperglycemia • RH, relative hazard • WHO, World Health Organization
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Doi, M. Kubo, K. Yonemoto, T. Ninomiya, M. Iwase, H. Arima, J. Hata, Y. Tanizaki, M. Iida, and Y. Kiyohara Fasting Plasma Glucose Cutoff for Diagnosis of Diabetes in a Japanese Population J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3425 - 3429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Boden-Albala, S. Cammack, J. Chong, C. Wang, C. Wright, T. Rundek, M. S.V. Elkind, M. C. Paik, and R. L. Sacco Diabetes, Fasting Glucose Levels, and Risk of Ischemic Stroke and Vascular Events: Findings from the Northern Manhattan Study (NOMAS) Diabetes Care, June 1, 2008; 31(6): 1132 - 1137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Bianchi, R. Miccoli, G. Penno, and S. Del Prato Primary Prevention of Cardiovascular Disease in People With Dysglycemia Diabetes Care, February 1, 2008; 31(Supplement_2): S208 - S214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. N. Pilichiewicz, R. Chaikomin, I. M. Brennan, J. M. Wishart, C. K. Rayner, K. L. Jones, A. J. P. M. Smout, M. Horowitz, and C. Feinle-Bisset Load-dependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E743 - E753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J. Suppl., June 1, 2007; 9(suppl_C): C3 - C74. [Full Text] [PDF]
|
|
|
|
 |
|
 R. E Pratley and G. Matfin Review: Pre-diabetes: clinical relevance and therapeutic approach The British Journal of Diabetes & Vascular Disease, May 1, 2007; 7(3): 120 - 129. [Abstract] [PDF]
|
|
|
|
|
|
D. M. Nathan, M. B. Davidson, R. A. DeFronzo, R. J. Heine, R. R. Henry, R. Pratley, and B. Zinman Impaired Fasting Glucose and Impaired Glucose Tolerance: Implications for care Diabetes Care, March 1, 2007; 30(3): 753 - 759. [Full Text] [PDF]
|
|
|
|
|
|
J. S. Pankow, D. K. Kwan, B. B. Duncan, M. I. Schmidt, D. J. Couper, S. Golden, and C. M. Ballantyne Cardiometabolic Risk in Impaired Fasting Glucose and Impaired Glucose Tolerance: The Atherosclerosis Risk in Communities Study Diabetes Care, February 1, 2007; 30(2): 325 - 331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J., January 1, 2007; 28(1): 88 - 136. [Full Text] [PDF]
|
|
|
|
|
|
O. Cohen, R. Basu, G. Bock, C. Dalla Man, M. Campioni, A. Basu, G. Toffolo, C. Cobelli, and R. A. Rizza Prediction of Postprandial Glycemic Exposure: Utility of fasting and 2-h glucose measurements alone and in combination with assessment of body composition, fitness, and strength Diabetes Care, December 1, 2006; 29(12): 2708 - 2713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden Cardiovascular Disease Diabetes Care, May 1, 2006; 29(5): 1160 - 1166. [Full Text] [PDF]
|
|
|
|
|
|
F. Cavalot, A. Petrelli, M. Traversa, K. Bonomo, E. Fiora, M. Conti, G. Anfossi, G. Costa, and M. Trovati Postprandial Blood Glucose Is a Stronger Predictor of Cardiovascular Events Than Fasting Blood Glucose in Type 2 Diabetes Mellitus, Particularly in Women: Lessons from the San Luigi Gonzaga Diabetes Study J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 813 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Vancheri, M. Curcio, A. Burgio, S. Salvaggio, G. Gruttadauria, M.C. Lunetta, R. Dovico, and M. Alletto Impaired glucose metabolism in patients with acute stroke and no previous diagnosis of diabetes mellitus QJM, December 1, 2005; 98(12): 871 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Wen, T. Y. D. Cheng, S. P. Tsai, H. L. Hsu, and S. L. Wang Increased Mortality Risks of Pre-Diabetes (Impaired Fasting Glucose) in Taiwan Diabetes Care, November 1, 2005; 28(11): 2756 - 2761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shiraiwa, H. Kaneto, T. Miyatsuka, K. Kato, K. Yamamoto, A. Kawashima, T. Kanda, M. Suzuki, E. Imano, M. Matsuhisa, et al. Postprandial Hyperglycemia Is a Better Predictor of the Progression of Diabetic Retinopathy Than HbA1c in Japanese Type 2 Diabetic Patients Diabetes Care, November 1, 2005; 28(11): 2806 - 2807. [Full Text] [PDF]
|
|
|
|
|
|
C. Abletshauser, P. Brunel, K.-H. Usadel, and M. Hanefeld Effect of nateglinide and glimepiride in reducing postprandial hyperglycaemia in patients with type 2 diabetes mellitus The British Journal of Diabetes & Vascular Disease, March 1, 2005; 5(2): 93 - 99. [Abstract] [PDF]
|
|
|
|
 |
|
 E. B. Levitan, Y. Song, E. S. Ford, and S. Liu Is Nondiabetic Hyperglycemia a Risk Factor for Cardiovascular Disease?: A Meta-analysis of Prospective Studies Arch Intern Med, October 25, 2004; 164(19): 2147 - 2155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Selvin, S. Marinopoulos, G. Berkenblit, T. Rami, F. L. Brancati, N. R. Powe, and S. H. Golden Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus Ann Intern Med, September 21, 2004; 141(6): 421 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Golay, C. Guitard, M. Hoyer, J. O Logan, and P. C Brunel Assessment of postprandial glucose: relationship between a standardised continental breakfast and the oral glucose tolerance test The British Journal of Diabetes & Vascular Disease, September 1, 2004; 4(5): 321 - 324. [Abstract] [PDF]
|
|
|
|
|
|
D. G. O'Donovan, S. Doran, C. Feinle-Bisset, K. L. Jones, J. H. Meyer, J. M. Wishart, H. A. Morris, and M. Horowitz Effect of Variations in Small Intestinal Glucose Delivery on Plasma Glucose, Insulin, and Incretin Hormones in Healthy Subjects and Type 2 Diabetes J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3431 - 3435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Barrett-Connor, E.-G. V. Giardina, A. K. Gitt, U. Gudat, H. O. Steinberg, and D. Tschoepe Women and Heart Disease: The Role of Diabetes and Hyperglycemia Arch Intern Med, May 10, 2004; 164(9): 934 - 942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hanefeld, J. L. Chiasson, C. Koehler, E. Henkel, F. Schaper, and T. Temelkova-Kurktschiev Acarbose Slows Progression of Intima-Media Thickness of the Carotid Arteries in Subjects With Impaired Glucose Tolerance Stroke, May 1, 2004; 35(5): 1073 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Expert Committee on the Diagnosis and Classificati Follow-up Report on the Diagnosis of Diabetes Mellitus Clin. Diabetes, April 1, 2004; 22(2): 71 - 79. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Fonseca, C. Desouza, S. Asnani, and I. Jialal Nontraditional Risk Factors for Cardiovascular Disease in Diabetes Endocr. Rev., February 1, 2004; 25(1): 153 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Follow-up Report on the Diagnosis of Diabetes Mellitus Diabetes Spectr, January 1, 2004; 17(1): 51 - 59. [Full Text] [PDF]
|
|
|
|
|
|
The Expert Committee on the Diagnosis and Classifi Follow-up Report on the Diagnosis of Diabetes Mellitus Diabetes Care, November 1, 2003; 26(11): 3160 - 3167. [Full Text] [PDF]
|
|
|
|
|
|
A. Pilichiewicz, D. O'Donovan, C. Feinle, Y. Lei, J. M. Wishart, L. Bryant, J. H. Meyer, M. Horowitz, and K. L. Jones Effect of Lipase Inhibition on Gastric Emptying of, and the Glycemic and Incretin Responses to, an Oil/Aqueous Drink in Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3829 - 3834. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-L. Chiasson, R. G. Josse, R. Gomis, M. Hanefeld, A. Karasik, and M. Laakso Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose Tolerance: The STOP-NIDDM Trial JAMA, July 23, 2003; 290(4): 486 - 494. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Suzuki, M. Fukushima, M. Usami, M. Ikeda, A. Taniguchi, Y. Nakai, T. Matsuura, A. Kuroe, K. Yasuda, T. Kurose, et al. Factors Responsible for Development From Normal Glucose Tolerance to Isolated Postchallenge Hyperglycemia Diabetes Care, April 1, 2003; 26(4): 1211 - 1215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Ferrannini Pre-diabetes: to treat or not to treat? The British Journal of Diabetes & Vascular Disease, January 1, 2003; 3(1_suppl): S2 - S5. [Abstract] [PDF]
|
|
|
|
|
|
C. Saloranta, C. Guitard, E. Pecher, P. de Pablos-Velasco, K. Lahti, P. Brunel, and L. Groop Nateglinide Improves Early Insulin Secretion and Controls Postprandial Glucose Excursions in a Prediabetic Population Diabetes Care, December 1, 2002; 25(12): 2141 - 2146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Davidson Counterpoint: The Oral Glucose Tolerance Test Is Superfluous Diabetes Care, October 1, 2002; 25(10): 1883 - 1885. [Full Text] [PDF]
|
|
|
|
|
|
Q. Qiao, K. Pyorala, M. Pyorala, A. Nissinen, J. Lindstrom, R. Tilvis, and J. Tuomilehto Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose Eur. Heart J., August 2, 2002; 23(16): 1267 - 1275. [Abstract] [PDF]
|
|
|
|
|
|
G. Slama The Diabetes Prevention Program: will it really change the way we manage glycaemia? The British Journal of Diabetes & Vascular Disease, July 1, 2002; 2(4): 319 - 322. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |